Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Biomedicines|October 23, 2021
A DNA Methylation-Based Gene Signature Can Predict Triple-Negative Breast Cancer DiagnosisSaioa Mendaza, David Guerrero-Setas, Iñaki Monreal-Santesteban, et al.Clinical Epigenetics|February 3, 2017
<i>CDH22</i> hypermethylation is an independent prognostic biomarker in breast cancerEsperanza Martín-Sánchez, Saioa Mendaza, Ane Ulazia-Garmendia, et al.International Journal of Molecular Sciences|February 6, 2020
ADAM12 is A Potential Therapeutic Target Regulated by Hypomethylation in Triple-Negative Breast CancerSaioa Mendaza, Ane Ulazia-Garmendia, Iñaki Monreal-Santesteban, et al.International Journal of Molecular Sciences|March 25, 2020
Absence of Nuclear p16 Is a Diagnostic and Independent Prognostic Biomarker in Squamous Cell Carcinoma of the CervixSaioa Mendaza, Joaquín Fernández-Irigoyen, Enrique Santamaría, et al.Cancers|April 30, 2021
Understanding the Molecular Mechanism of miR-877-3p Could Provide Potential Biomarkers and Therapeutic Targets in Squamous Cell Carcinoma of the CervixSaioa Mendaza, Joaquín Fernández-Irigoyen, Enrique Santamaría, et al.Oncotarget|February 9, 2017
CHL1 hypermethylation as a potential biomarker of poor prognosis in breast cancerEsperanza Martín-Sánchez, Saioa Mendaza, Ane Ulazia-Garmendia, et al.Scientific Reports|July 13, 2024
Building on the clinical applicability of ctDNA analysis in non-metastatic pancreatic ductal adenocarcinomaIbone Labiano, Ana E Huerta, Maria Alsina, et al.Pageof 1